VC  jVen Capital

     Office Locations:

P.O. Box 60207
Potomac, MD 20859



  • Early
  • Growth



  • Life Sciences & Healthcare
  • Medical Device



    jVen is a privately held life sciences investment management company. jVen is a venture capital and growth equity investor with a focus in the areas of personalized medicine, genetics, and medical devices. The firm was established in 2007 by Evan Jones, a successful entrepreneur in the life sciences and molecular diagnostics fields. Prior to forming jVen Capital Mr. Jones was co-founder, Chairman and CEO of Digene Corporation, a publicly traded biotechnology company focused on womens health and molecular diagnostic testing.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Evan Jones Managing Member


    Portfolio companies include:

      CAS Medical Systems
        web link

        web link

        web link

      Signature Genomic Laboratories
        web link

        web link

        web link


    Recent News: